Logo image of ALBOU.PA

BOURRELIER GROUP (ALBOU.PA) Stock Fundamental Analysis

EPA:ALBOU - Euronext Paris - Matif - FR0000054421 - Common Stock - Currency: EUR

50  +2 (+4.17%)

Fundamental Rating

3

Taking everything into account, ALBOU scores 3 out of 10 in our fundamental rating. ALBOU was compared to 51 industry peers in the Specialty Retail industry. While ALBOU seems to be doing ok healthwise, there are quite some concerns on its profitability. ALBOU is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

ALBOU had negative earnings in the past year.
In the past year ALBOU had a positive cash flow from operations.
Of the past 5 years ALBOU 4 years were profitable.
Each year in the past 5 years ALBOU had a positive operating cash flow.
ALBOU.PA Yearly Net Income VS EBIT VS OCF VS FCFALBOU.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M -20M 40M -40M 60M 80M

1.2 Ratios

With a Return On Assets value of -0.72%, ALBOU perfoms like the industry average, outperforming 47.06% of the companies in the same industry.
ALBOU has a Return On Equity of -1.24%. This is comparable to the rest of the industry: ALBOU outperforms 47.06% of its industry peers.
Industry RankSector Rank
ROA -0.72%
ROE -1.24%
ROIC N/A
ROA(3y)2.09%
ROA(5y)0.87%
ROE(3y)3.33%
ROE(5y)1.42%
ROIC(3y)N/A
ROIC(5y)N/A
ALBOU.PA Yearly ROA, ROE, ROICALBOU.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10 -10 20

1.3 Margins

In the last couple of years the Profit Margin of ALBOU has declined.
ALBOU's Operating Margin has declined in the last couple of years.
The Gross Margin of ALBOU (37.89%) is comparable to the rest of the industry.
ALBOU's Gross Margin has improved in the last couple of years.
ALBOU does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 37.89%
OM growth 3Y-55.81%
OM growth 5YN/A
PM growth 3Y-37.2%
PM growth 5Y-49.52%
GM growth 3Y1.89%
GM growth 5Y1.57%
ALBOU.PA Yearly Profit, Operating, Gross MarginsALBOU.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20 40

More info and screens

5

2. Health

2.1 Basic Checks

ALBOU does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for ALBOU remains at a similar level compared to 1 year ago.
Compared to 5 years ago, ALBOU has more shares outstanding
Compared to 1 year ago, ALBOU has an improved debt to assets ratio.
ALBOU.PA Yearly Shares OutstandingALBOU.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M
ALBOU.PA Yearly Total Debt VS Total AssetsALBOU.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M

2.2 Solvency

An Altman-Z score of 2.28 indicates that ALBOU is not a great score, but indicates only limited risk for bankruptcy at the moment.
ALBOU has a Altman-Z score (2.28) which is comparable to the rest of the industry.
A Debt/Equity ratio of 0.40 indicates that ALBOU is not too dependend on debt financing.
ALBOU has a Debt to Equity ratio of 0.40. This is in the better half of the industry: ALBOU outperforms 68.63% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.4
Debt/FCF N/A
Altman-Z 2.28
ROIC/WACCN/A
WACC6.44%
ALBOU.PA Yearly LT Debt VS Equity VS FCFALBOU.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100M 200M 300M

2.3 Liquidity

ALBOU has a Current Ratio of 2.95. This indicates that ALBOU is financially healthy and has no problem in meeting its short term obligations.
ALBOU has a Current ratio of 2.95. This is amongst the best in the industry. ALBOU outperforms 90.20% of its industry peers.
ALBOU has a Quick Ratio of 2.17. This indicates that ALBOU is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 2.17, ALBOU belongs to the top of the industry, outperforming 90.20% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.95
Quick Ratio 2.17
ALBOU.PA Yearly Current Assets VS Current LiabilitesALBOU.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M 400M 500M

More info and screens

1

3. Growth

3.1 Past

The earnings per share for ALBOU have decreased strongly by -135.75% in the last year.
ALBOU shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -46.77% yearly.
ALBOU shows a decrease in Revenue. In the last year, the revenue decreased by -2.02%.
Measured over the past years, ALBOU shows a small growth in Revenue. The Revenue has been growing by 5.44% on average per year.
EPS 1Y (TTM)-135.75%
EPS 3Y-36.38%
EPS 5Y-46.77%
EPS Q2Q%-72.81%
Revenue 1Y (TTM)-2.02%
Revenue growth 3Y1.3%
Revenue growth 5Y5.44%
Sales Q2Q%-0.36%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ALBOU.PA Yearly Revenue VS EstimatesALBOU.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M
ALBOU.PA Yearly EPS VS EstimatesALBOU.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 0.5 1 1.5 2 2.5

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

ALBOU reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ALBOU.PA Price Earnings VS Forward Price EarningsALBOU.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, ALBOU is valued a bit cheaper than the industry average as 76.47% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 5.15
ALBOU.PA Per share dataALBOU.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40 50

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

6

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 6.42%, ALBOU is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 5.04, ALBOU pays a better dividend. On top of this ALBOU pays more dividend than 98.04% of the companies listed in the same industry.
ALBOU's Dividend Yield is rather good when compared to the S&P500 average which is at 2.44.
Industry RankSector Rank
Dividend Yield 6.42%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
ALBOU.PA Yearly Dividends per shareALBOU.PA Yearly Dividends per shareYearly Dividends per share 2018 2019 2024 1 2 3

5.3 Sustainability

DP0%
EPS Next 2YN/A
EPS Next 3YN/A
ALBOU.PA Yearly Income VS Free CF VS DividendALBOU.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M -20M 40M -40M 60M 80M

More info and screens

BOURRELIER GROUP

EPA:ALBOU (5/8/2025, 7:00:00 PM)

50

+2 (+4.17%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)02-26 2025-02-26
Earnings (Next)07-16 2025-07-16
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap311.00M
Analysts34.29
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 6.42%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.06
P/FCF N/A
P/OCF 12.01
P/B 0.9
P/tB 1.02
EV/EBITDA 5.15
EPS(TTM)-0.69
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.08
FCFYN/A
OCF(TTM)4.16
OCFY8.33%
SpS47.33
BVpS55.77
TBVpS49.18
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.72%
ROE -1.24%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 37.89%
FCFM N/A
ROA(3y)2.09%
ROA(5y)0.87%
ROE(3y)3.33%
ROE(5y)1.42%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)1.67%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-55.81%
OM growth 5YN/A
PM growth 3Y-37.2%
PM growth 5Y-49.52%
GM growth 3Y1.89%
GM growth 5Y1.57%
F-Score2
Asset Turnover0.49
Health
Industry RankSector Rank
Debt/Equity 0.4
Debt/FCF N/A
Debt/EBITDA 6.82
Cap/Depr 89.16%
Cap/Sales 8.97%
Interest Coverage N/A
Cash Conversion 127.18%
Profit Quality N/A
Current Ratio 2.95
Quick Ratio 2.17
Altman-Z 2.28
F-Score2
WACC6.44%
ROIC/WACCN/A
Cap/Depr(3y)22.4%
Cap/Depr(5y)18.81%
Cap/Sales(3y)1.88%
Cap/Sales(5y)1.72%
Profit Quality(3y)208.14%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-135.75%
EPS 3Y-36.38%
EPS 5Y-46.77%
EPS Q2Q%-72.81%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-2.02%
Revenue growth 3Y1.3%
Revenue growth 5Y5.44%
Sales Q2Q%-0.36%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-268.87%
EBIT growth 3Y-55.23%
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y92.36%
FCF growth 3Y-26.39%
FCF growth 5Y104.82%
OCF growth 1Y4251.12%
OCF growth 3Y-20.2%
OCF growth 5Y58.94%